Rodríguez Ana Cecilia, Morera Lidia Ana, Bratti Concepción, Herrero Rolando, Cox J Thomas, Morales Jorge, Alfaro Mario, Hutchinson Martha, Castle Philip E, Hildesheim Allan, Schiffman Mark
Proyecto Epidemiológico Guanacaste, FUCODOCSA, San José, Costa Rica.
J Low Genit Tract Dis. 2004 Apr;8(2):132-8. doi: 10.1097/00128360-200404000-00009.
To assess the screening performance of direct visual inspection with acetic acid and x2 magnification (VIAM) in a previously screened population, as performed by experienced gynecologic nurses with minimal training in VIAM.
Performance of VIAM was evaluated in 2,080 women from a population-based cohort in Guanacaste, Costa Rica, 5 years after they had negative enrollment results of conventional and liquid-based cytologic analysis, cervigram, and human papillomavirus DNA by Hybrid Capture Tube Test (Digene Corporation, Gaithersburg, MD). The VIAM results were compared with repeat conventional Pap smears, liquid-based cytologic examinations, and cervicography, with adjudication of differences by reference to MY09/MY11 L1 consensus primer polymerase chain reaction detection of oncogenic human papillomavirus DNA.
Less than 5% of women were classified as having positive results using VIAM. The VIAM positivity was also very low among women with high-grade squamous intraepithelial lesion conventional Pap smear results (8.3%), high-grade squamous intraepithelial lesion liquid-based cytologic results (6.3%), or cervigrams suggesting cervical intraepithelial neoplasia 2,3 or cancer (30%). The VIAM positivity was not associated with human papillomavirus DNA positivity.
As we practiced it, VIAM was not sensitive for detection of possibly serious incident cervical lesions in this previously screened population where cytologic screening is in place.
评估由经验丰富但在醋酸染色肉眼观察及 x2 倍放大检查(VIAM)方面接受过极少培训的妇科护士,对先前已筛查人群进行醋酸染色肉眼观察及 x2 倍放大检查(VIAM)的筛查性能。
对来自哥斯达黎加瓜纳卡斯特省一个基于人群队列的 2080 名女性进行 VIAM 性能评估,这些女性在常规和液基细胞学分析、宫颈造影以及采用杂交捕获管检测法(Digene 公司,马里兰州盖瑟斯堡)检测人乳头瘤病毒 DNA 的入组结果均为阴性 5 年后。将 VIAM 结果与重复的传统巴氏涂片、液基细胞学检查及宫颈造影结果进行比较,并通过参照致癌性人乳头瘤病毒 DNA 的 MY09/MY11 L1 共识引物聚合酶链反应检测来判定差异。
使用 VIAM 时,不到 5%的女性被归类为结果阳性。在传统巴氏涂片结果为高级别鳞状上皮内病变的女性中,VIAM 阳性率也非常低(8.3%);在液基细胞学结果为高级别鳞状上皮内病变的女性中,VIAM 阳性率为 6.3%;在宫颈造影提示宫颈上皮内瘤变 2、3 级或癌症的女性中,VIAM 阳性率为 30%。VIAM 阳性与人类乳头瘤病毒 DNA 阳性无关。
就我们的实践情况而言,在这个先前已进行细胞学筛查的人群中,VIAM 对于检测可能的严重宫颈病变事件并不敏感。